Related Experiment Video
Updated: Jun 29, 2026
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Editorial review: targets for glioma treatment: from bench to bedside
Purpose Of Review:
Progress in molecular mechanisms and pathogenesis of malignant gliomas opens new therapeutic possibilities.
Recent Findings:
Recent developments in the field of tumour biology have elucidated signalling pathways and genes involved in the development of gliomas, which represent new potential therapeutic targets, and many targeted therapies are currently being tested in clinical trials. Except for the antiangiogenic drugs, the results have been modest, because of the heterogeneity of malignant gliomas and redundant pathways, suggesting that combination therapies may be more appropriate. The recent finding that only a minority of tumour cells are capable of self-renewal (tumour stem cells) leads to focus on genes specifically involved in stem cell self-renewal and proliferation.
Summary:
Antiangiogenic drugs already have proved efficacy. Targeting of tumour-specific alterations and drugs more specifically directed against tumour stem cells may provide significant progress in future treatment of gliomas.
Insights
Targeting malignant gliomas shows promise. New therapies focus on tumor stem cells and specific genetic alterations, potentially improving treatment outcomes.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Malignant gliomas are complex tumors with evolving molecular insights.
- Understanding signaling pathways and genes is crucial for developing targeted therapies.
Discussion:
- Current targeted therapies show modest results due to glioma heterogeneity and pathway redundancy.
- Combination therapies are being explored as a more effective strategy.
- Tumor stem cells, responsible for self-renewal, are a key focus for novel treatments.
Key Insights:
- Antiangiogenic drugs have demonstrated efficacy in glioma treatment.
- Targeting tumor-specific alterations offers a promising therapeutic avenue.
- Focusing on tumor stem cell-specific genes may lead to significant advancements.
Outlook:
- Future glioma treatment will likely involve targeting tumor-specific alterations and stem cells.
- Combination therapies hold potential for overcoming treatment resistance.
- Continued research into molecular mechanisms will drive therapeutic innovation.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...